1525-139X/asset/olbannercenter.gif?v=1&s=31bd21532938c94b3455abef15a75d9b98218560)
Long-Term Performance of the Hemodialysis Reliable Outflow (HeRO) Device: The 56-Month Follow-Up of the First Clinical Trial Patient
Article first published online: 13 APR 2010
DOI: 10.1111/j.1525-139X.2010.00713.x
© 2010 Wiley Periodicals, Inc.
Additional Information
How to Cite
Nassar, G. M. (2010), Long-Term Performance of the Hemodialysis Reliable Outflow (HeRO) Device: The 56-Month Follow-Up of the First Clinical Trial Patient. Seminars in Dialysis, 23: 229–232. doi: 10.1111/j.1525-139X.2010.00713.x
Publication History
- Issue published online: 13 APR 2010
- Article first published online: 13 APR 2010
- Abstract
- Article
- References
- Cited By
Abstract
The Hemodialysis Reliable Outflow (HeRO®) Vascular Access Device is a novel long-term subcutaneous dialysis graft, ideally suited for catheter-dependent patients and patients dialyzing with failing fistulas or grafts due to venous outflow stenosis. This case presentation depicts the clinical course of the first patient to enter a Food and Drug Administration approved clinical trial and receive the HeRO device. The course of this patient over 56 months of follow-up provides the longest experience with the HeRO device to-date. In this patient, the HeRO device provided long-term dialysis access patency in conjunction with adequate dialysis and a low intervention rate.